Edition:
United States

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,526JPY
22 Jun 2017
Change (% chg)

¥29 (+1.94%)
Prev Close
¥1,497
Open
¥1,516
Day's High
¥1,529
Day's Low
¥1,511
Volume
2,094,600
Avg. Vol
1,748,658
52-wk High
¥1,748
52-wk Low
¥1,251

Latest Key Developments (Source: Significant Developments)

Aequus Pharmaceuticals enters into agreement with Santen Pharmaceutical's unit
Tuesday, 13 Jun 2017 09:00am EDT 

June 13 (Reuters) - Aequus Pharmaceuticals Inc -:Has entered into an exclusive agreement in Canada with a unit of Santen Pharmaceutical.Under agreement, Aequus and Santen will plan to co-commercialize an undisclosed ophthalmology therapeutic product.Aequus Pharmaceuticals - as per agreement, santen will be responsible for product manufacturing, distribution, co will be responsible for field activities.Net product revenues will be split between aequus and santen over a ten-year term.  Full Article

Santen Pharmaceutical to retire treasury shares
Wednesday, 14 Dec 2016 02:10am EST 

Santen Pharmaceutical Co Ltd <4536.T>: Says it to retire 8,300,000 shares (2 percent stake) of its common stock on Dec. 29 .Says the total shares outstanding will be 406,005,015 shares after the retirement.  Full Article

Santen Pharmaceutical unit sets up pharmaceutical JV in China
Tuesday, 30 Aug 2016 03:13am EDT 

Santen Pharmaceutical Co Ltd <4536.T>: Says its China-based unit set up a JV in Chongqing, China, with a China-based company, Cory Pharmaceutical Co., LTD . Says the JV is capitalized at 200 million yuan .Says the unit is holding 49 percent stake in the JV.  Full Article

SANTEN PHARMACEUTICAL raises year-end dividend forecast for FY 2016
Tuesday, 23 Feb 2016 02:00am EST 

SANTEN PHARMACEUTICAL CO LTD:Raised year-end dividend forecast to 13 yen per share from 12 yen per share for FY ending March 2016.  Full Article

SANTEN PHARMACEUTICAL assigns anti-rheumatic pharmaceuticals business to Hyperion Pharma
Monday, 3 Aug 2015 03:00am EDT 

SANTEN PHARMACEUTICAL CO LTD:Assigned its anti-rheumatic pharmaceuticals business to Hyperion Pharma, under a simplified company-split method, effective Aug. 3.  Full Article

More From Around the Web

BRIEF-Aequus Pharmaceuticals enters into agreement with Santen Pharmaceutical's unit

* Has entered into an exclusive agreement in Canada with a unit of Santen Pharmaceutical